Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1


Medical Devices

Pulmonx

Glendon E. French

Manu Joshi

Nick Pizzuti

Jon Biggs

Laure F.

Narinder Singh Shargill

Martin Schneider

Young Lee

Todd Galski

Tanner Johnson

Steve Wallace P.e.

Jim Outlaw

Jim Bobbitt

Conor McGuire

William Long

Marcee Maroney

Lisa Paul

Anna Gawlicka

David Lehman

Narinder S. Shargill

Mahtab Fatemi

Jérôme Erath

Sarah Huber

Kelly M. Shriner

Beran Rose

Sri Radhakrishnan

The Customer Service and Patient Support Team at Pulmonx provides comprehensive assistance to both patients and healthcare providers regarding the Zephyr Endobronchial Valve treatment for COPD/emphysema. This team handles inquiries, manages patient cases, supports reimbursement processes, and ensures positive customer experiences across both domestic and international markets. Their goal is to facilitate a smooth, supportive journey for patients undergoing the procedure and to optimize the overall service experience for all stakeholders.

Customer Service and Patient Support Team

Sales Team

Leadership Team

Marketing

Customer Service and Patient Support Team

About

Team members

Other teams at Pulmonx

Sales Team

Leadership Team

Marketing